| Treatment with anti-NAP monoclonal antibody reduces disease severity in murine model of novel angiogenic protein-induced or ovalbumin-induced arthritis. | |
| | |
MedLine Citation:
|
PMID: 23286942 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Rheumatoid arthritis (RA) is a polyarticular inflammatory, angiogenic disease. Synovial angiogenesis contributes to inflammation in RA. In this study we have developed an arthritic model in rats using a novel angiogenic protein (NAP), isolated from human synovial fluid of RA patients. We produced anti-NAP monoclonal antibodies (mAbs) and investigated the therapeutic efficacy of the same in adjuvant-induced or NAP-induced arthritis as a model of human RA. The treatment of arthritic rats with anti-NAP mAbs resulted in effective amelioration of paw oedema, radiological arthritic characteristics, serum levels of vascular endothelial growth factor (VEGF) and NAP, compared to that of untreated arthritic animals. Further, profiling of angiogenic markers such as synovial microvessel density, angiogenesis, CD31, VEGF and fms-like tyrosine kinase (Flt1) by immunohistochemistry both in arthritic and anti-NAP mAb-treated animals revealed the efficacy of mAb as an anti-angiogenic functional antibody. Therefore, NAP may be an attractive target to design anti-angiogenic and anti-arthritic therapies to control the pathogenesis of arthritis. |
| | |
Authors:
|
N B Nataraj; J Krishnamurthy; B P Salimath |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical and experimental immunology Volume: 171 ISSN: 1365-2249 ISO Abbreviation: Clin. Exp. Immunol. Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-01-04 Completed Date: 2013-03-12 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 0057202 Medline TA: Clin Exp Immunol Country: England |
Other Details:
|
Languages: eng Pagination: 155-63 Citation Subset: IM |
Copyright Information:
|
© 2012 British Society for Immunology. |
Affiliation:
|
Department of Biotechnology, University of Mysore, Karnataka, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Angiogenesis Inducing Agents / immunology, isolation & purification Animals Antibodies, Monoclonal / therapeutic use* Arthritis, Experimental / immunology, therapy* Arthritis, Rheumatoid / immunology, therapy* Calcium-Binding Proteins / immunology Cells, Cultured Disease Models, Animal Disease Progression Female Humans Immunotherapy / methods* Male Membrane Proteins / immunology Middle Aged Ovalbumin / immunology Rats Rats, Wistar Synovial Membrane / drug effects, immunology |
| Chemical | |
Reg. No./Substance:
|
0/Angiogenesis Inducing Agents; 0/Antibodies, Monoclonal; 0/Calcium-Binding Proteins; 0/Membrane Proteins; 9006-59-1/Ovalbumin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Experimental models to investigate the function of dendritic cell subsets: challenges and implicatio...
Next Document: Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmun...